Innogene Co Ltd
344860
Company Profile
Business description
Innogene Co Ltd is a bio-technology company. The company provides treatment solutions using stem cells and databases for hair loss, psoriasis, skin regeneration and hair follicle formation. Also, the company helps in hair loss diagnosis.
Contact
No. 301, 28, Digital-ro 33-gil
Guro-gu
Seoul
KORT: +82 221082294
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
59
Stocks News & Analysis
stocks
Short-term pain for long-term gain for undervalued ASX share
Cost reductions lower our profit estimates but should lead to improved long-term outcomes.
stocks
Qantas earnings: Jetstar capitalising on weaker domestic competition
Qantas’ budget brand performing well, with segment earnings up 55%.
stocks
Nvidia Earnings: No signs of a slowdown in demand for AI chips
A selloff in Nvidia stock on the earnings news looks like a buying opportunity to us.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,028.30 | 98.90 | -1.08% |
| CAC 40 | 7,654.25 | 53.65 | -0.70% |
| DAX 40 | 23,487.33 | 550.00 | -2.29% |
| Dow JONES (US) | 45,295.81 | 249.07 | -0.55% |
| FTSE 100 | 9,116.69 | 79.65 | -0.87% |
| HKSE | 25,395.16 | 101.39 | -0.40% |
| NASDAQ | 21,279.63 | 175.92 | -0.82% |
| Nikkei 225 | 41,945.68 | 364.81 | -0.86% |
| NZX 50 Index | 13,054.58 | 78.58 | -0.60% |
| S&P 500 | 6,415.54 | 44.72 | -0.69% |
| S&P/ASX 200 | 8,757.70 | 101.30 | -1.14% |
| SSE Composite Index | 3,820.98 | 37.15 | -0.96% |